Chronic Hepatitis b: Clinical Trials

4 trials for Chronic Hepatitis b, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Active not recruiting 4

Follow Chronic Hepatitis b: new trials by email Literature Review of Chronic Hepatitis b trials Research Report on Chronic Hepatitis b

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients
Empagliflozin 10 MG, Placebo pills - Chronic Hepatitis b, NAFLD
Phase 4Active not recruitingThe University of Hong Kong1062022-01-022026-01-30
Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection
Tenofovir Alafenamide 25 MG - Safety Issues, Chronic Hepatitis B
Phase 4Active not recruitingTaichung Veterans General Hospital522021-06-222026-05-04
Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue
Vemlidy - Chronic Hepatitis b, Hepatitis B Reactivation
Phase 4Active not recruitingNational Taiwan University Hospital2602020-09-092026-02-24
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
Tenofovir Alafenamide - Chronic Hepatitis b
Phase 4Active not recruitingYoung-Suk Lim7802019-02-182024-12-17

Narrower conditions

Hepatitis B, Chronic (4)  ·  Fibrosis (1)  ·  Hepatitis (1)  ·  Liver Cirrhosis (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Patient Compliance (1)

Broader conditions

Blood-Borne Infections (4)  ·  Chronic Disease (4)  ·  Communicable Diseases (4)  ·  DNA Virus Infections (4)  ·  Digestive System Diseases (4)  ·  Disease Attributes (4)  ·  Hepadnaviridae Infections (4)  ·  Hepatitis B (4)  ·  Hepatitis, Chronic (4)  ·  Hepatitis, Viral, Human (4)  ·  Infections (4)  ·  Liver Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Virus Diseases (4)

Interventions

tenofovir alafenamide (3)  ·  empagliflozin (1)

Sponsors

National Taiwan University Hospital (1)  ·  Taichung Veterans General Hospital (1)  ·  The University of Hong Kong (1)  ·  Young-Suk Lim (1)

Countries

Taiwan (2)  ·  Hong Kong (1)  ·  South Korea (1)

Top investigators

Ka Shing Cheung, MD, MPH (1)  ·  Teng-Yu Lee, MD, PhD (1)  ·  Tung-Hung Su, MD, PhD (1)  ·  Young-Suk Lim, M.D, Ph D (1)

Results publications

PMID 27230467, PMID 28404091, PMID 28404092, PMID 28427875, PMID 29405329, PMID 29696665, PMID 31199513, PMID 31271737, PMID 31777965, PMID 32087795, PMID 32282538, PMID 32304611, PMID 33217163, PMID 33404182, PMID 39914435